Photobiomodulation in Age-Related Macular Degeneration: A Mitochondrial Bioenergetic Framework and Translational Perspective.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic framework paper without systematic methodology or new human data.
PubMed 42514168 · doi:10.3390/life16071098
What was done
The authors conducted a targeted narrative review of experimental and clinical literature evaluating photobiomodulation (PBM), retinal mitochondrial function, and metabolism in age-related macular degeneration (AMD) to develop a conceptual bioenergetic framework.
What was found
The abstract reports no quantitative clinical or experimental numbers. It outlines mechanisms by which PBM affects mitochondrial activity (including cytochrome c oxidase modulation, nitric oxide photodissociation, and redox signaling) and proposes a conceptual framework where clinical benefit requires dosing within a specific bioenergetic window when retinal mitochondrial dysfunction is still partially reversible.
Why it matters
The paper proposes a unifying bioenergetic model to help explain clinical outcome variability and guide translational research for early to intermediate AMD.
Limits
This is a narrative review presenting mechanistic theory and framework proposals without new clinical trial data. No search parameters, systematic study selection criteria, sample sizes, or quantitative outcome measures are reported in the abstract.
Cited by
- partial Red light, near-infrared, and infrared light therapy promote faster muscle recovery, improve skin health and acne, accelerate wound healing, reduce pain and inflammation, enhance mitochondrial function, and improve vision.